Skip to main content
Clinical Trials/IRCT20150221021159N6
IRCT20150221021159N6
Not yet recruiting
Phase 3

Evaluation of the effect of HemoHIM supplement for the prevention of ventilator associated pneumonia in critically ill patients

Esfahan University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
30
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Gaining informed consent
  • Adult patients undergoing mechanical ventilation for more than 48 hours

Exclusion Criteria

  • Diagnosis of acute respiratory distress syndrome or pneumonia at intensive care unit (ICU) admission
  • Existence of immunodeficiency and leukopenia

Outcomes

Primary Outcomes

Not specified

Similar Trials